GLUCOSE LEVELS

This study investigates biochemical changes in the aqueous humor and blood of bovine eyes after death to improve methods for estimating the post-mortem interval (PMI) in forensic investigations. The aqueous humor, a clear fluid in the eye's anterior chamber, is relatively isolated from external factors and may serve as a more reliable fluid for PMI estimation compared to blood, which is subject to faster and more variable biochemical changes. Key biochemical markers (e.g., glucose, electrolytes, and proteins) will be measured in both fluids at different times after death. The results obtained will determine if the aqueous humor has more gradual and predictable biochemical changes than the blood or if it changes more rapidly and inconsistently as compared to the blood. This will further suggests that aqueous humor may or may not provide a more stable timeline for estimating PMI, especially when compared to blood samples. This study will be a support to the use of either blood or aqueous humor as a biomarker in forensic settings and calls for further research on post-mortem biochemical dynamics in humans and environmental influences on fluid degradation.

This study investigates biochemical changes in the aqueous humor and blood of bovine eyes after death to improve methods for estimating the post-mortem interval (PMI) in forensic investigations. The aqueous humor, a clear fluid in the eye's anterior chamber, is relatively isolated from external factors and may serve as a more reliable fluid for PMI estimation compared to blood, which is subject to faster and more variable biochemical changes. Key biochemical markers (e.g., glucose, electrolytes, and proteins) will be measured in both fluids at different times after death. The results obtained will determine if the aqueous humor has more gradual and predictable biochemical changes than the blood or if it changes more rapidly and inconsistently as compared to the blood. This will further suggests that aqueous humor may or may not provide a more stable timeline for estimating PMI, especially when compared to blood samples. This study will be a support to the use of either blood or aqueous humor as a biomarker in forensic settings and calls for further research on post-mortem biochemical dynamics in humans and environmental influences on fluid degradation.

Glucagon-like peptide-1 (GLP-1) is an incretin hormone widely recognized for its role in enhancing insulin secretion and improving glycemic control. Beyond its antidiabetic effects, emerging evidence suggests that GLP-1 may influence renal physiology, hematological and glucose levels. This study investigates the subacute toxicity effects of MaxGLP-1 a novel analogue of GLP-1 administration on the kidney, hematological and blood glucose levels in experimental models over a 28 day period. A total of 20 rats were divided into four groups and were fed and given water daily. Group 1 was the control and was exposed to standard feeding and water only, Group 2 was administered 10mg/kg of MaxGLP-1, Group 3 was administered 60mg/kg MaxGLP-1 drug while Group 3 was administered 600mg/kg doses of MaxGLP-1. At the end of the study, animals were sacrificed, the kidneys were harvested and taken to the laboratory to be examined, blood samples were also collected and centrifuged to obtain the serum and were subjected to biochemical assays. Findings showed dose-related changes in serum creatinine and urea, indicating possible renal stress. Haematological analysis revealed mild but notable shifts in erythrocyte and leukocyte indices, while glucose levels decreased significantly across treatment groups. Overall, Max GLP- 1 exhibited hypoglycaemic effects with minimal haematological disturbances, though higher doses suggested early signs of renal compromise. These results highlight the need for cautious dose optimization and further investigation into long-term safety